2QQ-33630-72162
5 vaccinations
4 coded responses
35 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 190 / PA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WC4-25868-74653
Child or adolescent in my care · Male · 2022-06-22
48J-24818-33506
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Photophobia — Feeling: Good · HeadacheFree text: Light sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Ocular discomfort, Visual impairment — Feeling: Good · Nausea, Abdominal painFree text: Vision changesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-05-14
- 2021-06-03
-
2021-11-26
Dose 3 — Pfizer-BioNTech
- 2022-03-01
-
2022-05-29
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Dose 4 — Moderna
-
2022-07-30
Survey response — days 1–6 daily, dose 4MedDRA: Respiratory tract congestion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-31
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-08-03
- 2022-08-04
- 2022-08-07
- 2022-08-12
- 2022-08-19
- 2022-08-27
- 2022-09-02
- 2022-09-09
-
2022-10-20
Dose 5 — ModernaCo-administered: Tetanus
-
2022-10-21
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-11-26 | Pfizer-BioNTech | No |
| 4 | 2022-07-29 | Moderna | No |
| 5 | 2022-10-20 | Moderna | Tetanus |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Light sensitivity
Systemic reaction (other): Vision changes
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ○ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release